While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With this in mind, we are always looking at value, growth, and momentum trends to discover great companies.
Of these, value investing is easily one of the most popular ways to find great stocks in any market environment. Value investors use tried-and-true metrics and fundamental analysis to find companies that they believe are undervalued at their current share price levels.
Luckily, Zacks has developed its own Style Scores system in an effort to find stocks with specific traits. Value investors will be interested in the system's "Value" category. Stocks with both "A" grades in the Value category and high Zacks Ranks are among the strongest value stocks on the market right now.
One stock to keep an eye on is CRH Medical . CRHM is currently holding a Zacks Rank of #2 (Buy) and a Value grade of A.
We should also highlight that CRHM has a P/B ratio of 1.37. Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total assets minus total liabilities. This stock's P/B looks attractive against its industry's average P/B of 4.08. Over the past 12 months, CRHM's P/B has been as high as 2.51 and as low as 0.54, with a median of 1.48.
Value investors also love the P/S ratio, which is calculated by simply dividing a stock's price with the company's sales. This is a prefered metric because revenue can't really be manipulated, so sales are often a truer performance indicator. CRHM has a P/S ratio of 1.61. This compares to its industry's average P/S of 4.45.
These figures are just a handful of the metrics value investors tend to look at, but they help show that CRH Medical is likely being undervalued right now. Considering this, as well as the strength of its earnings outlook, CRHM feels like a great value stock at the moment.
Image: Bigstock
Should Value Investors Buy CRH Medical (CRHM) Stock?
While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With this in mind, we are always looking at value, growth, and momentum trends to discover great companies.
Of these, value investing is easily one of the most popular ways to find great stocks in any market environment. Value investors use tried-and-true metrics and fundamental analysis to find companies that they believe are undervalued at their current share price levels.
Luckily, Zacks has developed its own Style Scores system in an effort to find stocks with specific traits. Value investors will be interested in the system's "Value" category. Stocks with both "A" grades in the Value category and high Zacks Ranks are among the strongest value stocks on the market right now.
One stock to keep an eye on is CRH Medical . CRHM is currently holding a Zacks Rank of #2 (Buy) and a Value grade of A.
We should also highlight that CRHM has a P/B ratio of 1.37. Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total assets minus total liabilities. This stock's P/B looks attractive against its industry's average P/B of 4.08. Over the past 12 months, CRHM's P/B has been as high as 2.51 and as low as 0.54, with a median of 1.48.
Value investors also love the P/S ratio, which is calculated by simply dividing a stock's price with the company's sales. This is a prefered metric because revenue can't really be manipulated, so sales are often a truer performance indicator. CRHM has a P/S ratio of 1.61. This compares to its industry's average P/S of 4.45.
These figures are just a handful of the metrics value investors tend to look at, but they help show that CRH Medical is likely being undervalued right now. Considering this, as well as the strength of its earnings outlook, CRHM feels like a great value stock at the moment.